Last $3.33 USD
Change Today -0.02 / -0.60%
Volume 4.3K
ABIO On Other Exchanges
As of 11:47 AM 05/31/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

11080 CirclePoint Road

Suite 140

Westminster, CO 80020

United States

Phone: 720-940-2200

Fax: 720-208-9261

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. The company’s primary product candidate, Gencaro (bucindolol hydrochloride), is a pharmacologically beta-blocker and mild vasodilator that it is evaluating in a clinical trial for the treatment of atrial fibrillation, in patients with heart failure and left ventricular systolic dysfunction. The company is testing hypothesis in a Phase 2B/3 clinical trial of Gencaro, known as GENETIC-AF. Strategy The key elements of the company’s strategy are to advance the development of Gencaro; build a cardiovascular pipeline; and leverage its existing assets. Research and Development For the year ended December 31, 2014, the company’s research and development expenses totaled $5.6 million.


The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABIO:US $3.33 USD -0.02

ABIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ABIO.
View Industry Companies

Industry Analysis


Industry Average

Valuation ABIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ARCA BIOPHARMA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at